Leonard Schleifer, cofounder and CEO of Regeneron Pharmaceuticals, built one of the most successful biotech companies in the world by combining scientific rigor with long-term investment in research. A trained neurologist turned entrepreneur, he launched Regeneron in 1988 and steered it through decades of discovery to blockbuster drugs such as Eylea, Dupixent, and leading monoclonal antibody therapies. Under his leadership, Regeneron became known for its genetics platform, deep scientific culture, and partnerships that accelerated medical breakthroughs. Schleifer’s blend of clinical expertise, business discipline, and research focus has made him a defining figure in the modern biotechnology landscape.

Lee Ainslie, founder and managing partner of Maverick Capital, is one of the most successful hedge fund managers from the original Tiger Cub generation, known for disciplined stock-picking, sector specialization, and rigorous research. After training under Julian Robertson at Tiger Management, Ainslie launched Maverick in 1993 and built it into a multibillion-dollar long/short equity platform with deep expertise in technology, healthcare, and consumer companies. Over three decades, he has produced strong returns with a patient, fundamentals-driven approach and an internal culture that emphasizes analytical depth and risk control. Ainslie is also active in philanthropy and governance, serving on nonprofit boards and promoting educational initiatives.

John Griffin, founder of Blue Ridge Capital, became one of the most respected hedge fund managers of his generation through his disciplined long/short equity strategy and reputation for deep fundamental research. A protégé of legendary investor Julian Robertson at Tiger Management, Griffin launched Blue Ridge in 1996 and built it into a multi-billion-dollar “Tiger Cub” fund known for concentrated bets on high-quality growth companies and sharp downside hedging. After closing the fund in 2017 to devote himself to philanthropy, he became CEO of Blue Ridge Foundation and a leading donor to education and medical research, combining investment principles with data-driven social impact initiatives.

Ed Hallen is the co‑founder and Chief Product Officer (later Chief Strategy Officer) of Klaviyo, the Boston-based SaaS platform powering email/SMS marketing and customer data for over 100,000 brands, including Unilever and Citizen Watches  . A systems engineering graduate from UVA and MIT Sloan MBA, he previously led product at Applied Predictive Technologies and held roles at Google before launching Team Engine in 2018.

David Walentas is the self-made real estate developer behind Two Trees Management, the Brooklyn firm that transformed Dumbo and Williamsburg from industrial decline into high-end residential and creative districts. A University of Virginia alumnus, Walentas began with a small Manhattan partnership in 1968 and leveraged $12 million to acquire nearly 2 million sq ft in Dumbo, reshaping it through bold vision and rezoning advocacy.